undamentalytics Newsletter
Sign in

Incyte income statement

In fiscal 2025, Incyte reported revenue of $5.14bn, up 21.2% on the year before, operating income of $1.51bn (a 29.5% margin) and net income of $1.29bn, or $6.41 per diluted share. Every line below comes from the company's 10-K and 10-Q filings; column headings link to the filing.

Income statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2009Dec 20092010Dec 20102011Dec 20112012Dec 20122013Dec 20132014Dec 20142015Dec 20152016Dec 20162017Dec 20172018Dec 20182019Dec 20192020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMSept 2026
Revenue9170942973555117541,1061,5361,8822,1592,6672,9863,3953,6964,2415,1416,011
Cost of revenue———————587994114131151207255312372439
Gross profit———————1,0481,4571,7882,0452,5352,8353,1883,4413,9294,7695,571
Research and development1191241792102603484805821,3261,1981,1542,2161,4581,5861,6282,6072,0503,436
Selling, general and administrative283258851101661973033664344695177401,0021,1561,2421,3761,435
Operating income−14014−1431−16−551145−243129402−264586579621611,515627
Interest expense32434446394746397222233222
Income before tax—−32−187−44−83−498107−312115487−2325705298343171,664796
Income tax———00−013164063−378188237284378393
Net income−212−32−187−44−83−487104−313109447−296949341598331,287403
Diluted EPS−$2.06−$0.26−$1.49−$0.34−$0.56−$0.29$0.03$0.54−$1.53$0.51$2.05−$1.36$4.27$1.52$2.65$0.15$6.41$1.96
Diluted shares (average)103m122m125m130m148m168m187m194m205m216m218m218m222m224m226m211m201m206m
EBITDA−12339−11631133796203−191184457−2126446477031511,608725

EBITDA is operating income plus depreciation and amortisation. EPS and share counts are restated for stock splits. A dash means the company did not report the line for that period; expense lines are shown as reported, so they need not add up to the totals when a company reports other items between them.

Compare with peers

Head to head: ARGX vs INCYINCY vs NBIXBIIB vs INCY

More: Biotechnology stocks compared, Health Care sector, rankings of US companies

Figures from Incyte's SEC filings (10-K and 10-Q), retrieved October 30, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Incyte.